Key result
Isolated ultrafiltration increased plasma levels of noradrenaline and angiotensin II, while CGRP continued to rise during isovolemic hemodialysis.
Why the study?
How do sequential ultrafiltration and isovolemic hemodialysis affect plasma concentrations of vasoactive agents and blood pressure in hemodialysis patients?
Observational
How do sequential ultrafiltration and isovolemic hemodialysis affect plasma concentrations of vasoactive agents and blood pressure in hemodialysis patients?
Hemodialysis patients respond to fluid removal by ultrafiltration with an increase in CGRP, noradrenaline, and angiotensin II, maintaining adequate blood pressure, whereas isovolemic hemodialysis leads to a decrease in vasoconstrictors and continued rise in vasodilatory CGRP, contributing to symptomatic hypotension.
Answers are grounded in this paper and cite their sources.
Alerts to potential hemodynamic instability during isovolemic hemodialysis; extends mechanistic insights into intradialytic hypotension but requires prospective validation.
Hypotension is a common and sometimes dangerous side effect of hemodialysis. Its etiology is multifactorial and largely unknown. Earlier studies on the role of endogenous blood pressure regulating agents such as catecholamines and renin have rendered conflicting results. We studied the influence of ultrafiltration and isovolemic hemodialysis separately on the plasma concentrations of the following blood pressure regulating agents: adrenaline, noradrenaline, dopamine, neuropeptide Y, calcitonin gene-related peptide (CGRP), renin (PRA), angiotensin II, vasopressin, aldosterone and cortisol. During isolated ultrafiltration, plasma levels of two strong vasoconstrictors (noradrenaline and angiotensin II) and one strong vasodilator (calcitonin gene-related peptide, CGRP) increased significantly (noradrenaline 3.24 +/- 0.60 nM to 4.31 +/- 0.55 nM; p = 0.032, angiotensin II 19.74 +/- 3.46 pmol/l to 28.49 +/- 7.24 pmol/l; p = 0.047) No symptomatic hypotension occurred. At the end of isovolemic hemodialysis, plasma levels of all the vasoconstricting agents had decreased to pretreatment values, but those of CGRP had continued to rise (from 85.3 +/- 17.6 pmol/l to 114.5 +/- 25.3 pmol/l, p = 0.031). During isovolemic hemodialysis, blood pressure fell to symptomatic levels, but was restored at the end of treatment. The study shows that hemodialysis patients respond to fluid removal by ultrafiltration with an increase in plasma levels of CGRP, noradrenaline and angiotensin II. The net effect is an appropriate vasoconstriction and adequate blood pressure is maintained during isolated ultrafiltration.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Odar‐Cederlöf et al. (1993) conducted an observational in Hemodialysis-induced hypotension. Isolated ultrafiltration and isovolemic hemodialysis vs. Pretreatment baseline was evaluated on Plasma concentrations of vasoactive agents (noradrenaline, angiotensin II, CGRP). Isolated ultrafiltration increased plasma levels of noradrenaline and angiotensin II, while CGRP continued to rise during isovolemic hemodialysis.
Synapse has enriched 10 related papers. Consider them for comparative context: